Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (982)
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
36,387
Price
$0.42
Total Value
$15.28K
Shares Held After
919,060
% of Holdings
3.8%
Liquidia Corp (LQDA)
SINGH RAMAN — Director
Shares
29,494
Price
$60.13
Total Value
$1.77M
Shares Held After
38,755
% of Holdings
43.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.13
Total Value
$1.53M
Shares Held After
1,098,095
% of Holdings
2.2%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
1,829
Price
$30.60
Total Value
$55.97K
Shares Held After
48,945
% of Holdings
3.6%
Pharvaris N.V. (PHVS)
Nassif David W. — CFO / CLO
Shares
10,000
Price
$30.31
Total Value
$303.08K
Shares Held After
120,300
% of Holdings
7.7%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
9,200
Price
$20.42
Total Value
$187.88K
Shares Held After
145,355
% of Holdings
6.0%
Pharvaris N.V. (PHVS)
Monges Viviane — Director
Shares
9,667
Price
$30.29
Total Value
$292.85K
Shares Held After
5,500
% of Holdings
63.7%
PepGen Inc. (PEPG)
Kasraian Kasra — Chief Technical Officer
Shares
1,233
Price
$1.41
Total Value
$1.74K
Shares Held After
50,074
% of Holdings
2.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
800
Price
$70.92
Total Value
$56.74K
Shares Held After
243,327
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,250
Price
$70.48
Total Value
$792.92K
Shares Held After
244,127
% of Holdings
4.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,072
Price
$69.22
Total Value
$351.10K
Shares Held After
255,377
% of Holdings
1.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
6,725
Price
$68.30
Total Value
$459.33K
Shares Held After
260,449
% of Holdings
2.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,256
Price
$67.57
Total Value
$152.43K
Shares Held After
267,174
% of Holdings
0.8%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.77
Total Value
$17.70K
Shares Held After
10,000
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Firestone Karen — Director
Shares
3,800
Price
$13.51
Total Value
$51.34K
Shares Held After
66,900
% of Holdings
5.7%
Moderna, Inc. (MRNA)
AFEYAN NOUBAR — Director
Shares
9,263
Price
$46.84
Total Value
$433.88K
Shares Held After
3,924
% of Holdings
70.2%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
12,820
Price
$6.15
Total Value
$78.84K
Shares Held After
700,000
% of Holdings
1.8%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,478
Price
$6.27
Total Value
$15.53K
Shares Held After
357,418
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
1,870
Price
$6.27
Total Value
$11.72K
Shares Held After
359,896
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Kelliher Mike — Chief Business Officer
Shares
2,900
Price
$6.27
Total Value
$18.18K
Shares Held After
361,766
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,405
Price
$6.27
Total Value
$15.07K
Shares Held After
417,972
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
2,427
Price
$6.27
Total Value
$15.21K
Shares Held After
420,377
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
3,166
Price
$6.27
Total Value
$19.84K
Shares Held After
422,804
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
1,846
Price
$6.27
Total Value
$11.57K
Shares Held After
261,066
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
2,209
Price
$9.04
Total Value
$19.96K
Shares Held After
285,009
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Bishop John E — Chief Technical and Quality Officer
Shares
2,306
Price
$6.27
Total Value
$14.45K
Shares Held After
336,845
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,455
Price
$6.27
Total Value
$9.12K
Shares Held After
229,078
% of Holdings
0.6%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
1,036
Price
$6.27
Total Value
$6.49K
Shares Held After
149,836
% of Holdings
0.7%
ARDELYX, INC. (ARDX)
Reilly Joseph James — Senior Vice President and Chief Accounting Officer
Shares
2,683
Price
$6.27
Total Value
$16.82K
Shares Held After
149,107
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,197
Price
$566.12
Total Value
$1.24M
Shares Held After
18,876
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,765
Price
$565.10
Total Value
$997.41K
Shares Held After
21,073
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,081
Price
$564.10
Total Value
$1.17M
Shares Held After
22,838
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,677
Price
$563.12
Total Value
$1.51M
Shares Held After
24,919
% of Holdings
9.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
920
Price
$562.01
Total Value
$517.05K
Shares Held After
27,596
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$560.03
Total Value
$179.21K
Shares Held After
28,516
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
28,836
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.42
Total Value
$90.63K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,259
Price
$566.02
Total Value
$1.28M
Shares Held After
40,673
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$564.87
Total Value
$1.04M
Shares Held After
42,932
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,242
Price
$563.77
Total Value
$1.26M
Shares Held After
44,772
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,760
Price
$562.98
Total Value
$990.84K
Shares Held After
47,014
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$561.97
Total Value
$516.45K
Shares Held After
48,774
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$560.03
Total Value
$156.81K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
49,973
% of Holdings
0.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
13,235
Price
$59.97
Total Value
$793.66K
Shares Held After
73,743
% of Holdings
15.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
53,447
Price
$59.10
Total Value
$3.16M
Shares Held After
86,978
% of Holdings
38.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
38,318
Price
$58.43
Total Value
$2.24M
Shares Held After
140,425
% of Holdings
21.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$18.01
Total Value
$180.10K
Shares Held After
0
% of Holdings
100.0%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
10,000
Price
$11.00
Total Value
$110.00K
Shares Held After
173,614
% of Holdings
5.4%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
14,028
Price
$6.27
Total Value
$87.92K
Shares Held After
1,720,033
% of Holdings
0.8%
Showing 1–50 of 982 transactions (page 1 of 20)